Intraperitoneal chemotherapy as first-line treatment of newly diagnosed advanced epithelial ovarian cancer: Two centers' data in China

被引：0
|
作者：
Xie, X. [1 ]
Shen, Y. [1 ]
Tang, S. [1 ]
Cheng, X. [1 ]
Lv, W. [1 ]
Wan, X. [1 ]
Chen, Z. [2 ]
机构：
[1] Zhejiang Univ, Sch Med, Womens Hosp, Hangzhou, Peoples R China
[2] Zhejiang Canc Hosp, Hangzhou, Zhejiang, Peoples R China
来源：
GYNECOLOGIC ONCOLOGY | 2020年 / 159卷
关键词：
D O I：
10.1016/j.ygyno.2020.05.649
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
761
引用
收藏
页码：348 / 348
页数：1
相关论文
共 50 条
  • [11] MEDx HRDetectCDx predicts the response of newly diagnosed advanced ovarian cancer patients in china to first-line maintenance treatment with niraparib
    Zuo, Jing
    Wang, Ke
    Cui, Zhumei
    Zhang, Hui
    Li, Qingshui
    Wang, Shuhe
    Sun, Lixin
    Zhang, Jun
    Zheng, Min
    Zhao, Hongqin
    Chen, Xiaoxiang
    Cheng, Xiaodong
    Hong, Li
    Gao, Yang
    Song, Wenhui
    Wang, Yu
    Zhao, Jiaxing
    Jiang, Zeyu
    Zhang, Yafei
    Wu, Lingying
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_1) : A316 - A316
  • [12] Docetaxel and cisplatin in combination as first-line chemotherapy for advanced epithelial ovarian cancer
    Vasey, PA
    Paul, J
    Birt, A
    Junor, EJ
    Reed, NS
    Symonds, RP
    Atkinson, R
    Graham, J
    Crawford, SM
    Coleman, R
    Thomas, H
    Davis, J
    Eggleton, SPH
    Kaye, SB
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (07) : 2069 - 2080
  • [13] CARBOPLATIN AND ETOPOSIDE AS FIRST-LINE CHEMOTHERAPY IN ADVANCED EPITHELIAL OVARIAN-CANCER
    EDELMANN, DZ
    PERETZ, T
    BARAK, V
    ANTEBY, SO
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1995, 5 (06) : 443 - 448
  • [14] Intraperitoneal chemotherapy in the first-line treatment of women with stage III epithelial ovarian cancer - A systematic review with melaanalyses
    Elit, Laurie
    Oliver, Thomas K.
    Covens, Allan
    Kwon, Janice
    Fung, Michael -Kee Fung
    Hirte, Holger W.
    Oza, Amit M.
    CANCER, 2007, 109 (04) : 692 - 702
  • [15] First line chemotherapy of advanced epithelial ovarian cancer
    Lhomme, C.
    Even, C.
    Morice, P.
    Balleyguier, C.
    Petrella, M. C.
    Gouy, S.
    Uzan, C.
    Duvillard, P.
    Pautier, P.
    BULLETIN DU CANCER, 2009, 96 (12) : 1207 - 1213
  • [16] Optimizing treatment selection and sequencing decisions for first-line maintenance therapy of newly diagnosed advanced ovarian cancer
    Goh, Jeffrey C. H.
    Gourley, Charlie
    Tan, David S. P.
    Nogueira-Rodrigues, Angelica
    Elghazaly, Hesham
    Pierre, Marc Edy
    Giornelli, Gonzalo
    Kim, Byoung-Gie
    Morales-Vasquez, Flavia
    Tyulyandina, Alexandra
    GYNECOLOGIC ONCOLOGY REPORTS, 2022, 42
  • [17] Systematic review of first-line chemotherapy for newly diagnosed postoperative patients with stage II, III, or IV epithelial ovarian cancer
    Covens, A
    Carey, M
    Bryson, P
    Verma, S
    Fung, MFK
    Johnston, M
    GYNECOLOGIC ONCOLOGY, 2002, 85 (01) : 71 - 80
  • [18] Bevacizumab with Chemotherapy as a First-Line Treatment for Advanced Ovarian Cancer in a Serbian Cohort
    Conic, Irena
    Nedovic, Bojan
    Stojnev, Slavica
    Todorovska, Ilinka
    Dimitrijevic, Aleksandra
    Krstic, Miljan
    Djordjevic, Ivana
    Djordjevic, Biljana
    MEDICINA-LITHUANIA, 2022, 58 (05):
  • [19] Systemic treatment of newly diagnosed advanced epithelial ovarian cancer: From chemotherapy to precision medicine
    Alejandro Perez-Fidalgo, J.
    Grau, Francisco
    Farinas, Lorena
    Oaknin, Ana
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2021, 158
  • [20] Hexamethylmelamine as Consolidation Treatment for Patients with Advanced Epithelial Ovarian Cancer in Complete Response after First-Line Chemotherapy
    Kwon, Yong Soon
    Nam, Joo-Hyun
    Kim, Dae-Yeon
    Suh, Dae-Shik
    Kim, Jong-Hyeok
    Kim, Yong Man
    Kim, Young Tak
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2009, 24 (04) : 679 - 683
12345